Oppenheimer Maintains Outperform Rating on Immunovant (IMVT) Following Q2 2026 Earnings

1 day ago 4

Sheryar Siddiq

Sat, November 29, 2025 astatine 12:29 PM CST 2 min read

Immunovant, Inc. (NASDAQ:IMVT) ranks among the best abbreviated compression stocks to bargain close now. Following the company’s fiscal second-quarter 2026 fiscal results, Oppenheimer reaffirmed its Outperform standing connected Immunovant, Inc. (NASDAQ:IMVT) connected November 11 with a terms people of $54. The company’s reported net per stock of -$0.73 fell abbreviated of the -$0.71 statement estimate. With $4.4 cardinal successful currency and nary indebtedness connected its equilibrium sheet, Immunovant, Inc. (NASDAQ:IMVT) maintains a beardown superior presumption successful contempt these deficits.

Source: Pixabay

The institution intends to people results from a proof-of-concept survey successful cutaneous lupus and preliminary objective information for IMVT-1402 successful ACPA+ difficult-to-treat rheumatoid arthritis successful 2026. According to Oppenheimer, the medicine is “positioned arsenic best-in-class” and has “considerable upside” arsenic it moves person to imaginable commercialization crossed aggregate indications.

Immunovant, Inc. (NASDAQ:IMVT) is besides investigating a 2nd cause candidate, batoclimab, successful mid-late-stage trials for 2 abstracted autoimmune conditions: GD and thyroid oculus illness (TED).

Immunovant, Inc. (NASDAQ:IMVT) is simply a clinical-stage immunology institution focused connected processing innovative therapies for autoimmune diseases. The company’s superior absorption is connected creating anti-FcRn (neonatal Fc receptor) antibodies which purpose to trim harmful immunoglobulin G (IgG) autoantibodies successful patients with assorted autoimmune conditions.

While we admit the imaginable of IMVT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.